Journal ArticleDOI
Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency
TLDR
The clinical and immunological variability of PAD is defined, how genetic defects identified in PAD have given insight into B-cell immunobiology is considered, and recent technological advances in genomics and the challenges associated with identifying causal variants are addressed.Abstract:
Predominantly antibody deficiency (PAD) is the most prevalent form of primary immunodeficiency, and is characterized by broad clinical, immunological and genetic heterogeneity. Utilizing the current gold standard of whole exome sequencing for diagnosis, pathogenic gene variants are only identified in less than 20% of patients. While elucidation of the causal genes underlying PAD has provided many insights into the cellular and molecular mechanisms underpinning disease pathogenesis, many other genes may remain as yet undefined to enable definitive diagnosis, prognostic monitoring and targeted therapy of patients. Considering that many patients display a relatively late onset of disease presentation in their 2nd or 3rd decade of life, it is questionable whether a single genetic lesion underlies disease in all patients. Potentially, combined effects of other gene variants and/or non-genetic factors, including specific infections can drive disease presentation. In this review, we define (1) the clinical and immunological variability of PAD, (2) consider how genetic defects identified in PAD have given insight into B-cell immunobiology, (3) address recent technological advances in genomics and the challenges associated with identifying causal variants, and (4) discuss how functional validation of variants of unknown significance could potentially be translated into increased diagnostic rates, improved prognostic monitoring and personalized medicine for PAD patients. A multidisciplinary approach will be the key to curtailing the early mortality and high morbidity rates in this immune disorder.read more
Citations
More filters
Posted Content
Clinical and immunologic phenotype associated with activated ă phosphoinositide 3-kinase delta syndrome 2: A cohort study
Elodie Elkaim,Bénédicte Neven,Julie Bruneau,Kanako Mitsui-Sekinaka,Aurélie Stanislas,Lucie Heurtier,Carrie L. Lucas,Helen F. Matthews,Marie-Céline Deau,Svetlana O. Sharapova,James Curtis,Janine Reichenbach,Catherine Glastre,David A. Parry,Gururaj Arumugakani,Elizabeth M. McDermott,Sara Sebnem Kilic,Motoi Yamashita,Despina Moshous,Hicham Lamrini,Burkhard Otremba,Andrew R. Gennery,Tanya I. Coulter,Isabella Quinti,Jean-Louis Stephan,Vassilios Lougaris,Nicholas Brodszki,Vincent Barlogis,Takaki Asano,Lionel Galicier,David Boutboul,Shigeaki Nonoyama,Andrew J. Cant,Kohsuke Imai,Capucine Picard,Sergey Nejentsev,Thierry Jo Molina,Michael J. Lenardo,Sinisa Savic,Marina Cavazzana,Alain Fischer,Anne Durandy,Sven Kracker +42 more
TL;DR: APDS2 is a combined immunodeficiency with a variable clinical phenotype and Complications are frequent, such as severe bacterial and viral infections, lymphoproliferation, and lymphoma similar to APDS1/PASLI-CD.
Journal Article
Mutations in lrba are associated with a syndrome of immune deficiency and autoimmunity
G Lopez-Herrera,Giacomo Tampella,Manuela Baronio,Massimiliano Vitali,Vassilios Lougaris,Alessandro Plebani,Q Pan-Hammarstroem,L Hammarstroem,Likun Du,Kjell Hultenby,Claudia M. Trujillo-Vargas,Kanchan Phadwal,Anna Katharina Simon,Michel Moutschen,Amos Etzioni,Srugo Ami.,Doron Melamed,Chonghai Liu,P Philippet,Vinciane Dideberg,Asghar Aghamohammadi,N Rezai,V Enright,Hans J. Stauss,P Herholz,Ulrich Salzer,Hermann Eibel,Dietmar Pfeifer,H Velkeen,EM Gertz,AA Schaeffer,Bodo Grimbacher +31 more
TL;DR: In this paper, the authors performed genetic linkage analysis in consanguineous families affected by hypogammaglobulinemia and concluded that mutations in LRBA cause an immune deficiency characterized by defects in B cell activation and autophagy and susceptibility to apoptosis.
Iconographies supplémentaires de l'article : Phosphatase and tensin homolog ( PTEN ) mutation can cause activated phosphatidylinositol 3-kinase ? syndrome–like immunodeficiency
Yuki Tsujita,Kanako Mitsui-Sekinaka,Kohsuke Imai,Tzu-Wen Yeh,Noriko Mitsuiki,Takaki Asano,Hidenori Ohnishi,Zenichiro Kato,Yujin Sekinaka,Kiyotaka Zaha,Tamaki Kato,Tsubasa Okano,Takehiro Takashima,Kaoru Kobayashi,Mitsuaki Kimura,Tomoaki Kunitsu,Yoshihiro Maruo,Hirokazu Kanegane,Masatoshi Takagi,Kenichi Yoshida,Yusuke Okuno,Hideki Muramatsu,Yuichi Shiraishi,Kenichi Chiba,Hiroko Tanaka,Satoru Miyano,Seiji Kojima,Seishi Ogawa,Osamu Ohara,Satoshi Okada,Masao Kobayashi,Tomohiro Morio,Shigeaki Nonoyama +32 more
TL;DR: PTEN loss-of-function mutations can cause APDS-like immunodeficiency because of aberrant PI3K pathway activation in lymphocytes.
Combined immunodeficiency and epstein-barr virus-induced b cell malignancy in humans with inherited cd70 deficiency
TL;DR: In this paper, the authors describe four patients from two unrelated families of different ethnicities with a primary immunodeficiency, predominantly manifesting as susceptibility to Epstein-Barr virus (EBV)related diseases.
References
More filters
Journal ArticleDOI
B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.
Elisabeth Salzer,Elisangela Santos-Valente,Stefanie Klaver,Stefanie Klaver,Sol A. Ban,Wolfgang Emminger,Nina Kathrin Prengemann,Wojciech Garncarz,Leonhard Müllauer,Renate Kain,Heidrun Boztug,Andreas Heitger,Klaus Arbeiter,Franz Eitelberger,Markus G. Seidel,Wolfgang Holter,Arnold Pollak,Winfried F. Pickl,Elisabeth Förster-Waldl,Kaan Boztug +19 more
TL;DR: In this paper, the authors investigated a patient from a consanguineous family suffering from recurrent infections and severe lupus-like autoimmunity, and combined homozygosity mapping and exome sequencing identified a biallelic splice-site mutation in protein C kinase δ (PRKCD), causing the absence of the corresponding protein product.
Journal ArticleDOI
Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond.
Guillem de Valles-Ibáñez,Ana Esteve-Solé,Mónica Piquer,E. Azucena González-Navarro,Jessica Hernandez-Rodriguez,Hafid Laayouni,Eva González-Roca,A.M. Plaza-Martín,Angela Deyà-Martínez,Andrea Martín-Nalda,Mónica Martínez-Gallo,Marina Garcia-Prat,Lucía del Pino-Molina,Ivon Cuscó,Marta Codina-Solà,Laura Batlle-Masó,Manuel Solís-Moruno,Tomas Marques-Bonet,Elena Bosch,Eduardo López-Granados,Juan I. Aróstegui,Pere Soler-Palacín,Roger Colobran,Jordi Yagüe,Laia Alsina,Manel Juan,Ferran Casals +26 more
TL;DR: This work explores the possibility of CVID being originated by an oligogenic model with the presence of heterozygous mutations in interacting proteins or by the accumulation of detrimental variants in particular immunological pathways, as well as performs association tests to detect association with rare genetic functional variation in the CVID cohort compared to healthy controls.
Journal ArticleDOI
Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4.
Sangmoon Lee,Jin Soo Moon,Cho Rong Lee,Hye-Eun Kim,Sun Mi Baek,Solha Hwang,Gyeong Hoon Kang,Jeong Kee Seo,Choong Ho Shin,Hyoung Jin Kang,Hyoung Jin Kang,Jae Sung Ko,Sung-Gyoo Park,Murim Choi,Murim Choi +14 more
Journal ArticleDOI
Whole-genome sequencing of a sporadic primary immunodeficiency cohort
Thaventhiran Jed.,Hana Lango Allen,Oliver S. Burren,William Rae,Daniel Greene,Emily Staples,Zinan Zhang,Zinan Zhang,Farmery Jhr.,Ilenia Simeoni,Elizabeth Rivers,Elizabeth Rivers,Jesmeen Maimaris,Jesmeen Maimaris,Christopher J. Penkett,Jonathan Stephens,Jonathan Stephens,Deevi Svv.,Alba Sanchis-Juan,Alba Sanchis-Juan,Nicholas Gleadall,Nicholas Gleadall,Moira Thomas,Moira Thomas,Ravishankar Sargur,Pavels Gordins,Helen Baxendale,Helen Baxendale,Matthew A. Brown,Paul Tuijnenburg,Paul Tuijnenburg,Austen Worth,Austen Worth,Steven Hanson,Steven Hanson,Rachel Linger,Matthew Buckland,Matthew Buckland,Paula Rayner-Matthews,Kimberly Gilmour,Kimberly Gilmour,Crina Samarghitean,Suranjith L. Seneviratne,Suranjith L. Seneviratne,David M. Sansom,David M. Sansom,Andy G. Lynch,Andy G. Lynch,Karyn Megy,Eva Ellinghaus,David Ellinghaus,David Ellinghaus,Silje F. Jørgensen,Tom H. Karlsen,Kathleen Stirrups,Antony J. Cutler,Dinakantha S. Kumararatne,Anita Chandra,Edgar Jdm.,A Herwadkar,Nichola Cooper,S Grigoriadou,Aarnoud Huissoon,Sarah Goddard,Stephen Jolles,Catharina Schuetz,F Boschann,Paul A. Lyons,Matthew E. Hurles,Sinisa Savic,Siobhan O. Burns,Siobhan O. Burns,Taco W. Kuijpers,Taco W. Kuijpers,Ernest Turro,Willem H. Ouwehand,Adrian J. Thrasher,Adrian J. Thrasher,Smith Kgc. +78 more
TL;DR: Whole-genome sequencing analysis of individuals with primary immunodeficiency identifies new candidate disease-associated genes and shows how the interplay between genetic variants can explain the variable penetrance and complexity of the disease.
Journal ArticleDOI
T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections
E. Bateman,Lisa Ayers,Ross Sadler,M Lucas,Ceri A. Roberts,A Woods,K. Packwood,John Burden,D Harrison,N Kaenzig,Martin Lee,Helen Chapel,Berne Ferry +12 more
TL;DR: There was a reduction in early differentiated CD4 andCD8 T cells and increased CD8 TEM in the CVID patients, particularly autoimmune cytopenia and polyclonal lymphoproliferation subgroups, suggesting a more activated T cell phenotype, due perhaps to an antigen‐driven process.
Related Papers (5)
Genetic Approaches to the Study of Gene Variants and Their Impact on the Pathophysiology of Type 2 Diabetes
The genetics of common kidney disease: a pathway toward clinical relevance
Paul E. Drawz,John R. Sedor +1 more